FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/09/094444 [Registered on: 09/09/2025] Trial Registered Prospectively
Last Modified On: 09/09/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   To Evaluate the efficacy of Arjuna Twaka Lepa in Vyanga. 
Scientific Title of Study   Analytical and Clinical Study of Arjuna Twaka Lepa in Vyanga 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr DC Singh Chauhan 
Designation  Campus Director and Head of Department 
Affiliation  Rishikul Campus Haridwar 
Address  P.G. Department of Dravyaguna, Rishikul Campus,Haridwar Uttrakhand

Hardwar
UTTARANCHAL
249401
India 
Phone  9411175362  
Fax    
Email  drdcschauhan@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr DC Singh Chauhan 
Designation  Campus Director and Head of Department 
Affiliation  Rishikul Campus Haridwar 
Address  P.G. Department of Dravyaguna, Rishikul Campus,Haridwar Uttrakhand


UTTARANCHAL
249401
India 
Phone  9411175362  
Fax    
Email  drdcschauhan@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Ayushi Uniyal 
Designation  Post Graduation Scholar 
Affiliation  Rishikul Campus Haridwar 
Address  P.G. Department of Dravyaguna, Rishikul Campus,Haridwar Uttrakhand

Hardwar
UTTARANCHAL
249401
India 
Phone  9520793882  
Fax    
Email  ayu101097@gmail.com  
 
Source of Monetary or Material Support  
Rishikul Campus Uttrakhand Ayurveda University Uttrakhand India Pin 249404 
 
Primary Sponsor  
Name  Rishikul Campus Haridwar 
Address  OPD no 1 Rishikul Campus Haridwar Uttrakhand Ayurveda University  
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
AYUSHI UNIYAL  RISHIKUL CAMPUS UTTRAKHAND AYURVEDA UNIVERSITY  OPD NO. 1 ,PG DEPARTMENT OF KAYACHIKITSA
Hardwar
UTTARANCHAL 
9520793882

ayu101097@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
INSTITUTIONAL ETHICAL COMMITEE  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:L811||Chloasma. Ayurveda Condition: VYANGAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Comparator ArmDrugClassical(1) Medicine Name: Kumkumadi Oil, Reference: Bhaisajya ratnavali Kshudra roga Adhikara Chapter 60 sloke no. 115-120, Route: Topical, Dosage Form: Taila, Dose: 4(drops), Frequency: od, Bhaishajya Kal: Abhakta, Duration: 45 Days, anupAna/sahapAna: No, Additional Information: -
2Intervention ArmDrugClassical(1) Medicine Name: Arjuna twaka Lepa, Reference: Ashtang hridaya uttara tantra chapter 32 shloke no.16, Route: Topical, Dosage Form: Lepa Churna, Dose: 1(NA), Frequency: od, Bhaishajya Kal: Abhakta, Duration: 45 Days, anupAna/sahapAna: No, Additional Information: -Arjuna twaka lepa will be prepared with navneeta.
 
Inclusion Criteria  
Age From  20.00 Year(s)
Age To  50.00 Year(s)
Gender  Both 
Details  Patients having clinical sign and Symptoms of Vyanga (Melasma).
Patients will be selected between the age ground of 20-50 years.
Patients will be selected irrespective of gender and religion.
Patients willingly participating in study trial.
Chronicity less than 5 years. 
 
ExclusionCriteria 
Details  1 Patients of age below 20 years and above 50 years.
2 Patients having secondary systemic illness.
3 Melasma due to Tubercular therapy or malignant cases.
4 Any kind of heriditary skin disorder like Nevi ,freckles etc.,
5 Patients taking OCP’s, pregnant women,lactating mothers. 
 
Method of Generating Random Sequence   Adaptive randomization, such as minimization 
Method of Concealment   Not Applicable 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Decrease in size and no. of lesion,decrease in darkness of pigmentation,  The assessment will be done 3 times at an interval of 15 days till 45 days during the treatment 
 
Secondary Outcome  
Outcome  TimePoints 
Decrease in hyperpigmentation lesions (Mandala)  The assessment will be done 3 times at an interval of 15 days till 45 days during the 
 
Target Sample Size   Total Sample Size="40"
Sample Size from India="40" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   20/09/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="8"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  
This study is a Randomised controlled clinical trial to determine the efficacy of Arjuna Twaka Lepa in Vyanga (Melasma).Melasma is a melanogenesis condition that causes hyperpigmentation and is characterized by symmetrical brown to gray-black macules and patches with serrated uneven borders.In Ayurveda it can be co-related to Vyanga. A total no. of 40 patients will be taken between the age group of 20 to 50 years for 45 days. Study will be conducted at OPD level in PG department of Kayachikitsa.   Assessment will be done on the basis of subjective and objectives parameters. Study will be clinical trial and result obtained will be tabulated and statistically analyzed using appropriate tests.The Aim is to Provide a safe and effective Ayurveda Treatment for Melasma with lesser side effects.

 
Close